User profiles for Ryan C. Ungaro
 | Ryan UngaroIcahn School of Medicine at Mount Sinai Verified email at mssm.edu Cited by 8083 |
Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international …
Background and Aims The impact of Coronavirus disease 2019 (COVID-19) on patients with
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …
inflammatory bowel disease (IBD) is unknown. We sought to characterize the clinical course …
Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2–related disease
… (C) We estimated the marginal mean expression of ACE2 and TMPRSS2 for male and
female at each region (ileum, colon, and rectum) and disease (CD and UC) group. P values are …
female at each region (ileum, colon, and rectum) and disease (CD and UC) group. P values are …
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Objective We sought to evaluate COVID-19 clinical course in patients with IBD treated with
different medication classes and combinations. Design Surveillance Epidemiology of …
different medication classes and combinations. Design Surveillance Epidemiology of …
Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …
because of their ability to ameliorate shared immune pathways across immune-mediated …
Deep remission at 1 year prevents progression of early Crohn's disease
… Conflicts of interest These authors disclose the following: Ryan C. Ungaro has served as
an advisory board member or consultant for Eli Lilly, Janssen, Pfizer, and Takeda and has …
an advisory board member or consultant for Eli Lilly, Janssen, Pfizer, and Takeda and has …
Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists
… Spencer: concept, literature search, drafting of manuscript and critical revision of the manuscript
for important intellectual content; Jean-Frederic Colombel and Ryan C. Ungaro: concept …
for important intellectual content; Jean-Frederic Colombel and Ryan C. Ungaro: concept …
Prevalence of migraine in patients with celiac disease and inflammatory bowel disease
Objective.— To assess the prevalence of headache in clinic and support group patients with
celiac disease and inflammatory bowel disease (IBD) compared with a sample of healthy …
celiac disease and inflammatory bowel disease (IBD) compared with a sample of healthy …
Impact of SARS-CoV-2 vaccination on inflammatory bowel disease activity and development of vaccine-related adverse events: results from PREVENT-COVID
Background Severe acute respiratory syndrome coronavirus 2 vaccination is recommended
for all individuals with inflammatory bowel disease (IBD), including those on …
for all individuals with inflammatory bowel disease (IBD), including those on …
What should gastroenterologists and patients know about COVID-19?
RC Ungaro, T Sullivan, JF Colombel… - Clinical Gastroenterology …, 2020 - cghjournal.org
Amid the recent emergence of coronavirus disease 2019 (COVID-19), gastroenterologists are
frequently being asked by their patients about this virus and any necessary precautions to …
frequently being asked by their patients about this virus and any necessary precautions to …
Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn's disease
RC Ungaro, S Aggarwal, O Topaloglu… - Alimentary …, 2020 - Wiley Online Library
Background There is an increasing body of evidence showing that earlier use of biologics
improves clinical outcomes in Crohn's disease (CD). Aim To perform a systematic review and …
improves clinical outcomes in Crohn's disease (CD). Aim To perform a systematic review and …